You are here: Industry Insights > Preclinical

News List

Bio-Techne, Elpiscience Enter Strategic Anti-Cancer Alliance b3cnewswire
April 23, 2019
Elpiscience will have access to multiple antibodies from Bio-Techne's product portfolio for use in the development of biopharmaceuticals...
Triphase Accelerator Initiates Phase I Trial of TRPH-222 contractpharma
April 02, 2019
Next-Gen Antibody-Drug Conjugate developed using Catalent’s SMARTag ADC Technology
WuXi STA Mfg. Facility Passes GMP Inspection contractpharma
March 28, 2019
New drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European Medical Products Agency
Gilead, Agenus Enter Immuno-Oncology Pact contractpharma
December 21, 2018
Gilead Sciences and Agenus Inc. have entered into an immuno-oncology (I-O) partnership for the development and commercialization of up to five novel immuno-oncology therapies.
Amgen, Molecular Partners Enter Immunotherapy Alliance contractpharma
December 21, 2018
Amgen and Molecular Partners AG, a biotech company developing DARPin therapeutics, have entered a collaboration and license agreement for the clinical development and commercialization of MP0310...
Lilly Acquires Hydra Biosciences’ Pain Asset contractpharma
December 18, 2018
Eli Lilly and Co. has entered an agreement with Hydra Biosciences to acquire all assets related to Hydra's preclinical program of TRPA1 antagonists, part of the Transient Receptor Potential (TRP) family of ion channels being studied for the potential trea
AC Immune & Lilly Partner for Alzheimer's contractpharma
December 17, 2018
AC Immune SA and Eli Lilly and Company have signed a license and collaboration agreement to research and develop tau aggregation inhibitor small molecules for the potential treatment
Entera & Amgen Sign Research Agreement contractpharma
December 12, 2018
Entera Bio has entered into a research collaboration and license agreement with Amgen in inflammatory disease and other serious illnesses.
Avacta, LG Chem Announce Collaboration contractpharma
December 12, 2018
Avacta Group and LG Chem Life Sciencesannounced a multi-target collaboration and development agreement. The agreement provides LG Chem with the exclusive rights to develop and commercialize, on a worldwide basis
Pacific Biomarkers Merges with Neomed-Labs contractpharma
November 27, 2018
Ampersand Capital Partners has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company Neomed-Labs. This merger brings together two bioanalytical

Previous page 1 2 Next page